医薬品受託開発製造(CDMO)アウトソーシングの世界市場2018-2022

【英語タイトル】Global Contract Development and Manufacturing Organization (CDMO) Outsourcing Market 2018-2022

Technavioが出版した調査資料(IRTNTR23191)・商品コード:IRTNTR23191
・発行会社(調査会社):Technavio
・発行日:2018年6月13日
・ページ数:97
・レポート言語:英語
・レポート形式:PDF
・納品方法:Eメール(受注後24時間以内)
・調査対象地域:グローバル
・産業分野:New Research Areas
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD3,500 ⇒換算¥381,500見積依頼/購入/質問フォーム
Five User(5名様閲覧用)USD4,000 ⇒換算¥436,000見積依頼/購入/質問フォーム
Enterprise License(同一法人内共有可)USD5,000 ⇒換算¥545,000見積依頼/購入/質問フォーム
販売価格オプションの説明
※お支払金額:換算金額(日本円)+消費税
※納期:即日〜2営業日(3日以上かかる場合は別途表記又はご連絡)
※お支払方法:納品日+5日以内に請求書を発行・郵送(請求書発行日より2ヶ月以内に銀行振込、振込先:三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能)
当調査レポートでは、医薬品受託開発製造(CDMO)アウトソーシングの世界市場について調査・分析し、市場概要、市場環境、医薬品受託開発製造(CDMO)アウトソーシング市場規模、製品別(低分子医薬品、生物学的製剤)分析、市場動向、競争環境、主要地域別市場規模(アメリカ、ヨーロッパ、アジアなど)、関連企業情報などを含め、以下の構成でお届け致します。
・エグゼクティブサマリー
・調査範囲・調査手法
・医薬品受託開発製造(CDMO)アウトソーシングの世界市場概要
・医薬品受託開発製造(CDMO)アウトソーシングの世界市場環境
・医薬品受託開発製造(CDMO)アウトソーシングの世界市場動向
・医薬品受託開発製造(CDMO)アウトソーシングの世界市場規模
・医薬品受託開発製造(CDMO)アウトソーシングの世界市場:業界構造分析
・医薬品受託開発製造(CDMO)アウトソーシングの世界市場:製品別(低分子医薬品、生物学的製剤)
・医薬品受託開発製造(CDMO)アウトソーシングの世界市場:地域別市場規模・分析
・医薬品受託開発製造(CDMO)アウトソーシングのアメリカ市場規模・予測
・医薬品受託開発製造(CDMO)アウトソーシングのヨーロッパ市場規模・予測
・医薬品受託開発製造(CDMO)アウトソーシングのアジア市場規模・予測
・医薬品受託開発製造(CDMO)アウトソーシングの主要国分析
・医薬品受託開発製造(CDMO)アウトソーシングの世界市場:意思決定フレームワーク
・医薬品受託開発製造(CDMO)アウトソーシングの世界市場:成長要因、課題
・医薬品受託開発製造(CDMO)アウトソーシングの世界市場:競争環境
・医薬品受託開発製造(CDMO)アウトソーシングの世界市場:関連企業情報(ベンダー分析)
【レポートの概要】

About contract development and manufacturing organization (CDMO)

Contract development and manufacturing organization (CDMO) cater to the companies in the pharmaceutical industry on a contractual basis. CDMOs provide pharmaceutical companies wide range of services comprising of drug development to drug manufacturing.
Technavio’s analysts forecast the Global Contract Development and Manufacturing Organization (CDMO) market to grow at a CAGR of 7.24% during the period 2018-2022.

Covered in this report
The report covers the present scenario and the growth prospects of the contract development and manufacturing organization (CDMO) market. To calculate the market size, the report considers the revenue generated from the sales of small molecules and biologics to companies in the pharmaceutical industry.

The market is divided into the following segments based on geography:
• Americas
• APAC
• EMEA

Technavio’s report, Global Contract Development and Manufacturing Organization (CDMO) market 2018-2022, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

Key vendors
• Aenova Group
• Catalent
• Famar
• Fareva
• Thermo Fisher Scientific

Market driver
• Increasing need for cost-effective solutions
• For a full, detailed list, view our report

Market challenge
• Issues related to distribution, logistics, and supply
• For a full, detailed list, view our report

Market trend
• Increasing number of strategic alliances
• For a full, detailed list, view our report

Key questions answered in this report
• What will the market size be in 2022 and what will the growth rate be?
• What are the key market trends?
• What is driving this market?
• What are the challenges to market growth?
• Who are the key vendors in this market space?
• What are the market opportunities and threats faced by the key vendors?
• What are the strengths and weaknesses of the key vendors?

You can request one free hour of our analyst’s time when you purchase this market report. Details are provided within the report.

【レポートの目次】

PART 01: EXECUTIVE SUMMARY
PART 02: SCOPE OF THE REPORT
PART 03: RESEARCH METHODOLOGY
PART 04: MARKET LANDSCAPE
• Market ecosystem
• Market characteristics
• Market segmentation analysis
PART 05: MARKET SIZING
• Market definition
• Market sizing 2017
• Market size and forecast 2017-2022
PART 06: FIVE FORCES ANALYSIS
• Bargaining power of buyers
• Bargaining power of suppliers
• Threat of new entrants
• Threat of substitutes
• Threat of rivalry
• Market condition
PART 07: MARKET SEGMENTATION BY PRODUCT
• Overview
• Comparison by product
• Small molecules – Market size and forecast 2017-2022
• Biologics – Market size and forecast 2017-2022
• Market opportunity by product
PART 08: CUSTOMER LANDSCAPE
PART 09: REGIONAL LANDSCAPE
• Geographical segmentation
• Regional comparison
• Americas – Market size and forecast 2017-2022
• EMEA – Market size and forecast 2017-2022
• APAC – Market size and forecast 2017-2022
• Key leading countries
• Market opportunity
PART 10: DECISION FRAMEWORK
PART 11: DRIVERS AND CHALLENGES
• Market drivers
• Market challenges
PART 12: MARKET TRENDS
• Increasing number of strategic alliances
• Advent of robotic process automation
• Closing skill gap between CDMOs and pharmaceutical companies
PART 13: VENDOR LANDSCAPE
• Overview
• Landscape disruption
PART 14: VENDOR ANALYSIS
• Vendors covered
• Vendor classification
• Market positioning of vendors
• Aenova Group
• Catalent
• Famar
• Fareva
• Thermo Fisher Scientific
PART 15: APPENDIX
• List of abbreviations



Exhibit 01: Parent market
Exhibit 02: Global pharmaceutical outsourcing market: Segments
Exhibit 03: Market characteristics
Exhibit 04: Global CDMO outsourcing market: Segments
Exhibit 05: Market definition – Inclusions and exclusions checklist
Exhibit 06: Market size 2017
Exhibit 07: Validation techniques employed for market sizing 2017
Exhibit 08: Global CDMO outsourcing market: Market size and forecast 2017-2022 ($ bn)
Exhibit 09: Global CDMO outsourcing market: Year-over-year growth 2018-2022 (%)
Exhibit 10: Five forces analysis 2017
Exhibit 11: Five forces analysis 2022
Exhibit 12: Bargaining power of buyers
Exhibit 13: Bargaining power of suppliers
Exhibit 14: Threat of new entrants
Exhibit 15: Threat of substitutes
Exhibit 16: Threat of rivalry
Exhibit 17: Market condition: Five forces 2017
Exhibit 18: Segmentation by product: Market share 2017-2022 (%)
Exhibit 19: Comparison by product
Exhibit 20: Small molecules: Market size and forecast 2017-2022 ($ bn)
Exhibit 21: Small molecule: Year-over-year growth 2018-2022 (%)
Exhibit 22: Biologics: Market size and forecast 2017-2022 ($ bn)
Exhibit 23: Biologics: Year-over-year growth 2018-2022 (%)
Exhibit 24: Market opportunity by product
Exhibit 25: Customer landscape
Exhibit 26: Segmentation by geography: Market share 2017-2022 (%)
Exhibit 27: Regional comparison
Exhibit 28: Americas: Market size and forecast 2017-2022 ($ bn)
Exhibit 29: Americas: Year-over-year growth 2018-2022 (%)
Exhibit 30: EMEA: Market size and forecast 2017-2022 ($ bn)
Exhibit 31: EMEA: Year-over-year growth 2018-2022 (%)
Exhibit 32: APAC: Market size and forecast 2017-2022 ($ bn)
Exhibit 33: APAC: Year-over-year growth 2018-2022 (%)
Exhibit 34: Key leading countries
Exhibit 35: Market opportunity
Exhibit 36: Vendor landscape
Exhibit 37: Landscape disruption
Exhibit 38: Vendors covered
Exhibit 39: Vendor classification
Exhibit 40: Market positioning of vendors
Exhibit 41: Aenova Group: Overview
Exhibit 42: Aenova Group: Business segments
Exhibit 43: Aenova Group: Organizational developments
Exhibit 44: Aenova Group: Geographic focus
Exhibit 45: Aenova Group: Key offerings
Exhibit 46: Catalent: Overview
Exhibit 47: Catalent: Business segments
Exhibit 48: Catalent: Organizational developments
Exhibit 49: Catalent: Geographic focus
Exhibit 50: Catalent: Segment focus
Exhibit 51: Catalent: Key offerings
Exhibit 52: Famar: Overview
Exhibit 53: Famar: Business segments
Exhibit 54: Famar: Organizational developments
Exhibit 55: Famar: Geographic focus
Exhibit 56: Famar: Key offerings
Exhibit 57: Fareva: Overview
Exhibit 58: Fareva: Business segments
Exhibit 59: Fareva: Organizational developments
Exhibit 60: Fareva: Geographic focus
Exhibit 61: Fareva: Key offerings
Exhibit 62: Thermo Fisher Scientific: Overview
Exhibit 63: Thermo Fisher Scientific: Business segments
Exhibit 64: Thermo Fisher Scientific: Organizational developments
Exhibit 65: Thermo Fisher Scientific: Geographic focus
Exhibit 66: Thermo Fisher Scientific: Segment focus
Exhibit 67: Thermo Fisher Scientific: Key offerings



【掲載企業】

Aenova Group, Catalent, Famar, Fareva, Thermo Fisher Scientific

★調査レポート[医薬品受託開発製造(CDMO)アウトソーシングの世界市場2018-2022] (コード:IRTNTR23191)販売に関する免責事項を必ずご確認ください。
★調査レポート[医薬品受託開発製造(CDMO)アウトソーシングの世界市場2018-2022]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆